Description

Neratinib Impurity 1 is a designated impurity standard used in the pharmaceutical development and quality control of the active pharmaceutical ingredient (API) Neratinib. This high-purity reference material is critical for ensuring the safety, efficacy, and regulatory compliance of the final drug product by enabling accurate identification, quantification, and control of this specific impurity. It is an essential tool for analytical laboratories, quality assurance departments, and research scientists working in oncology drug development, pharmaceutical manufacturing, and regulatory affairs.

Application

• Pharmaceutical Reference Standard: Primary use as a certified reference material for the identification and quantification of Neratinib Impurity 1 in drug substance and drug product batches.
• Analytical Method Development and Validation: Critical for developing, optimizing, and validating stability-indicating HPLC/UPLC methods for Neratinib.
• Quality Control and Batch Release Testing: Used in routine QC testing to monitor impurity profiles and ensure drug product specifications are met per ICH guidelines.
• Stability Studies: Employed to track the formation of this impurity under various stress conditions (e.g., heat, light, humidity) to establish shelf life.
• Regulatory Submissions: Provides essential data for regulatory filings (e.g., FDA, EMA) to demonstrate control strategy and impurity qualification.
• Process Chemistry Research: Used to study and optimize synthetic pathways to minimize the formation of this impurity during API manufacturing.

Basic Information

Product Name	Neratinib Impurity 1
CAS No.	1144516-20-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Neratinib Related Compound 1; Neratinib EP Impurity 1; Neratinib USP Impurity 1; HKI-272 Impurity 1; (2E)-N-[4-[[3-Chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide; UNII-9F3K6W8R6I
EINECS	Contact for details

Quality Control

Our Neratinib Impurity 1 is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC purity, identity confirmation (IR, MS), and residual solvent analysis, to ensure it meets the high standards required for pharmaceutical reference materials. A comprehensive Certificate of Analysis (COA) detailing batch-specific results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or Certificate of Analysis. The material should be kept in a dry environment and handled with appropriate personal protective equipment in a well-ventilated laboratory setting.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Retention time corresponds to reference standard
Identification (IR)	Spectrum matches reference spectrum
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Individual unknown impurity: ≤ 1.0% Total impurities: ≤ 5.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.